These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1591730)

  • 1. In vivo efficacy of a novel inhibitor of selected signal transduction pathways including calcium, arachidonate, and inositol phosphates.
    Kohn EC; Sandeen MA; Liotta LA
    Cancer Res; 1992 Jun; 52(11):3208-12. PubMed ID: 1591730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-function analysis of signal and growth inhibition by carboxyamido-triazole, CAI.
    Kohn EC; Felder CC; Jacobs W; Holmes KA; Day A; Freer R; Liotta LA
    Cancer Res; 1994 Feb; 54(4):935-42. PubMed ID: 8313384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antiproliferative and antimetastatic compound L651582 inhibits muscarinic acetylcholine receptor-stimulated calcium influx and arachidonic acid release.
    Felder CC; Ma AL; Liotta LA; Kohn EC
    J Pharmacol Exp Ther; 1991 Jun; 257(3):967-71. PubMed ID: 1646332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical antitumor efficacy of the polyamine analogue N1, N11-diethylnorspermine administered by multiple injection or continuous infusion.
    Bernacki RJ; Oberman EJ; Seweryniak KE; Atwood A; Bergeron RJ; Porter CW
    Clin Cancer Res; 1995 Aug; 1(8):847-57. PubMed ID: 9816054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of head and neck squamous cell carcinoma growth and invasion by the calcium influx inhibitor carboxyamido-triazole.
    Wu Y; Palad AJ; Wasilenko WJ; Blackmore PF; Pincus WA; Schechter GL; Spoonster JR; Kohn EC; Somers KD
    Clin Cancer Res; 1997 Nov; 3(11):1915-21. PubMed ID: 9815580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide.
    Shawver LK; Schwartz DP; Mann E; Chen H; Tsai J; Chu L; Taylorson L; Longhi M; Meredith S; Germain L; Jacobs JS; Tang C; Ullrich A; Berens ME; Hersh E; McMahon G; Hirth KP; Powell TJ
    Clin Cancer Res; 1997 Jul; 3(7):1167-77. PubMed ID: 9815796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IP6-induced growth inhibition and differentiation of HT-29 human colon cancer cells: involvement of intracellular inositol phosphates.
    Yang GY; Shamsuddin AM
    Anticancer Res; 1995; 15(6B):2479-87. PubMed ID: 8669811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo.
    Sebolt-Leopold JS; Dudley DT; Herrera R; Van Becelaere K; Wiland A; Gowan RC; Tecle H; Barrett SD; Bridges A; Przybranowski S; Leopold WR; Saltiel AR
    Nat Med; 1999 Jul; 5(7):810-6. PubMed ID: 10395327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase I trial of carboxyamido-triazole and paclitaxel for relapsed solid tumors: potential efficacy of the combination and demonstration of pharmacokinetic interaction.
    Kohn EC; Reed E; Sarosy GA; Minasian L; Bauer KS; Bostick-Bruton F; Kulpa V; Fuse E; Tompkins A; Noone M; Goldspiel B; Pluda J; Figg WD; Liotta LA
    Clin Cancer Res; 2001 Jun; 7(6):1600-9. PubMed ID: 11410496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of hedgehog signaling in ovarian cancer.
    Bhattacharya R; Kwon J; Ali B; Wang E; Patra S; Shridhar V; Mukherjee P
    Clin Cancer Res; 2008 Dec; 14(23):7659-66. PubMed ID: 19047091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carboxyamido-triazole (CAI), a signal transduction inhibitor induces growth inhibition and apoptosis in bladder cancer cells by modulation of Bcl-2.
    Perabo FG; Wirger A; Kamp S; Lindner H; Schmidt DH; Müller SC; Kohn EC
    Anticancer Res; 2004; 24(5A):2869-77. PubMed ID: 15517890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selenium regulates cyclooxygenase-2 and extracellular signal-regulated kinase signaling pathways by activating AMP-activated protein kinase in colon cancer cells.
    Hwang JT; Kim YM; Surh YJ; Baik HW; Lee SK; Ha J; Park OJ
    Cancer Res; 2006 Oct; 66(20):10057-63. PubMed ID: 17047069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of protein kinase C epsilon is oncogenic in rat colonic epithelial cells.
    Perletti GP; Folini M; Lin HC; Mischak H; Piccinini F; Tashjian AH
    Oncogene; 1996 Feb; 12(4):847-54. PubMed ID: 8632907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver metastasis models of colon cancer for evaluation of drug efficacy using NOD/Shi-scid IL2Rgammanull (NOG) mice.
    Hamada K; Monnai M; Kawai K; Nishime C; Kito C; Miyazaki N; Ohnishi Y; Nakamura M; Suemizu H
    Int J Oncol; 2008 Jan; 32(1):153-9. PubMed ID: 18097554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An anti-Ras cancer potential of PP1, an inhibitor specific for Src family kinases: in vitro and in vivo studies.
    He H; Hirokawa Y; Levitzki A; Maruta H
    Cancer J; 2000; 6(4):243-8. PubMed ID: 11038144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of beta-catenin inhibits the neoplastic growth of APC-mutant colon cancer cells.
    Roh H; Green DW; Boswell CB; Pippin JA; Drebin JA
    Cancer Res; 2001 Sep; 61(17):6563-8. PubMed ID: 11522655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of parathyroid hormone-related peptide by the Ras oncogene: role of Ras farnesylation inhibitors as potential therapeutic agents for hypercalcemia of malignancy.
    Aklilu F; Park M; Goltzman D; Rabbani SA
    Cancer Res; 1997 Oct; 57(20):4517-22. PubMed ID: 9377563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical investigation of a cytostatic calcium influx inhibitor in patients with refractory cancers.
    Kohn EC; Reed E; Sarosy G; Christian M; Link CJ; Cole K; Figg WD; Davis PA; Jacob J; Goldspiel B; Liotta LA
    Cancer Res; 1996 Feb; 56(3):569-73. PubMed ID: 8564973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Farnesyl protein transferase inhibitors as potential cancer chemopreventives.
    Kelloff GJ; Lubet RA; Fay JR; Steele VE; Boone CW; Crowell JA; Sigman CC
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):267-82. PubMed ID: 9107432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Raf kinase in cancer: therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway.
    Gollob JA; Wilhelm S; Carter C; Kelley SL
    Semin Oncol; 2006 Aug; 33(4):392-406. PubMed ID: 16890795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.